New Era of Regulatory T Cells in Tumor Immunity: Insights in Cancer Immunotherapy

Juang, C. M., Hung, C. F., Yeh, J. Y., Horng, H. C., Twu, N. F., Cheng, M. H., Wen, K. C., Yuan, C. C., Chao, K. C., Wu, T. C., & Yen, M. S. (2007). Regulatory T Cells: Potential Target in Anticancer Immunotherapy. Taiwanese Journal of Obstetrics & Gynecology, 46(3), 215-221. https://doi.org/10.29787/TJOG.200709.0007
莊其穆、葉濬毅、洪建夫、洪煥程、屠乃方、鄭敏慧、溫國璋、袁九重、趙灌中、吳子丑、顏明賢（2007）。Regulatory T Cells: Potential Use in Anti-cancer Immunotherapy。中華民國婦癌醫學雜誌，(2007年1)，1-10。https://doi.org/10.7010/JGO.200704.0001
Nicot, C. (2015). Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia. Journal of Oncology, 2015(), 213-223. https://doi.org/10.1155/2015/183590
Koehler, P., Schmidt, P., Hombach, A. A., Hallek, M., & Abken, H. (2012). Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia. Advances in Hematology, 2012(), 393-405. https://doi.org/10.1155/2012/595060
Chew, V., Toh, H. C., & Abastado, J. P. (2012). Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy. Journal of Oncology, 2012(), 361-370-038. https://doi.org/10.1155/2012/608406